AAAAAA

   
Results: 1-3 |
Results: 3
A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3
Authors: Coulie, PG Karanikas, V Colau, D Lurquin, C Landry, C Marchand, M Dorval, T Brichard, V Boon, T
Citation: Pg. Coulie et al., A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3, P NAS US, 98(18), 2001, pp. 10290-10295
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
Authors: Marchand, M van Baren, N Weynants, P Brichard, V Dreno, B Tessier, MH Rankin, E Parmiani, G Arienti, F Humblet, Y Bourlond, A Vanwijck, R Lienard, D Beauduin, M Dietrich, PY Russo, V Kerger, J Masucci, G Jager, E De Greve, J Atzpodien, J Brasseur, F Coulie, PG Van der Bruggen, P Boon, T
Citation: M. Marchand et al., Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1, INT J CANC, 80(2), 1999, pp. 219-230
Antigens recognized on human melanoma by cytolytic T lymphocytes
Authors: Brichard, V Boon, T
Citation: V. Brichard et T. Boon, Antigens recognized on human melanoma by cytolytic T lymphocytes, RESEARCH IN, 1998, pp. 51-96
Risultati: 1-3 |